View Clinical Trial (Medical Research Study)
Aliskiren and Amlodipine Effects on IR and ED in Patients With HTN and Metabolic Disease. - NCT00417170-90404(Clinical Trial 159685)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Santa Monica |
|
State:
|
|
CA |
| Zip Code: |
|
90404 |
| Conditions: |
|
High Blood Pressure - Metabolic Disease |
| Purpose: |
|
To compare the effects of 300 mg Aliskiren on endothelial dysfunction during cold pressor
test (myocardial blood flow by PET scan) and insulin sensitivity (hyperinsulinemic
euglycemic clamp) compared to 5 mg Amlodipine in patients with metabolic syndrome and
hypertension .
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion criteria:
-Male or female adults aged 18 to 65 years with metabolic syndrome, specifically: HTN,
HTN, IGT/IFG (but not diabetic) and abnormal MBF and euglycemic clamp.
Exclusion criteria:
- Presence of diabetes
- Ethnicity of African Americans
- Other protocol-defined inclusion/exclusion criteria may apply.
Other protocol-defined inclusion/exclusion criteria may apply. |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
August 16, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|